Malta vs Puerto Rico: Cause of death, by non-communicable diseases, female
Malta
84.5%
in 2021
Puerto Rico
85.1%
in 2021
Malta rank
19th
Puerto Rico rank
16th
Cause of death, by non-communicable diseases, female over time
- Malta
- Puerto Rico
How they compare
Puerto Rico currently reports 85.1% against 84.5% in Malta, a difference of 0.6%.
The two have swapped places 3 times across 6 shared years of data; in 2000 it was Malta ahead.
Malta ranks 19th and Puerto Rico ranks 16th of 185 countries.
Malta has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Malta | Puerto Rico | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 89.2% | 85.3% | 3.9% | Malta |
| 2010s | 90.4% | 88.7% | 1.6% | Malta |
| 2020s | 85.0% | 84.7% | 0.3% | Malta |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, female, Malta or Puerto Rico?
- Puerto Rico, at 85.1% against 84.5% in Malta as of 2021.
- What is the difference in cause of death, by non-communicable diseases, female between Malta and Puerto Rico?
- 0.6%, with Puerto Rico ahead.
- How many years of comparable data are there for Malta and Puerto Rico?
- 6 years are reported by both, from 2000 to 2021.
- How do Malta and Puerto Rico rank globally for cause of death, by non-communicable diseases, female?
- Malta ranks 19th and Puerto Rico ranks 16th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, female (% of total female deaths). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths due to non-communicable diseases divided by number of all female deaths, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.